Wikidata

(Q43189899)

English

Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma

scientific article published in January 2010

In more languages
default for all languages
No label defined

No description defined

Statements

title
Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20085583
retrieved
15 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43189899&oldid=1983228682"